U.S. Market for Cardiac Rhythm Management Devices 2008 (Executive Summary)

The U.S. market for cardiac rhythm management includes implantable cardiac defibrillators, pacemakers, cardiac resynchronization therapy devices, cardiac leads and external defibrillators. Over the forecast period, the cardiac resynchronization therapy market is estimated to see the largest growth of any market segment.

Please note that this is for the executive summary from the full report. The full version can be ordered by through the page linked to at the "Also available" link below.

EXECUTIVE SUMMARY
1.1 TOTAL MARKET FOR CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY, AND ABLATION DEVICES
1.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)
1.3 PACEMAKERS
1.4 CARDIAC RESYNCHRONIZATION THERAPY (CRT) DEVICES
1.5 EXTERNAL DEFIBRILLATORS
1.6 CARDIAC ABLATION
1.7 DIAGNOSTIC ELECTROPHYSIOLOGY DEVICES
1.8 ECG AND CARDIAC MONITORING PRODUCTS
1.9 LEADING COMPETITORS

EXECUTIVE SUMMARY
Chart 1-1: Total Cardiac Rhythm Management, Electrophysiology, and Ablation Market, U.S., 2004 – 2014
Chart 1-2: Cardiac Rhythm Management, Electrophysiology, and Ablation Market by Segment, U.S., 2014
Chart 1-3: Average Selling Price of Implantable Cardioverter Defibrillators, U.S., 2004 – 2014
Chart 1-4: Market for Automated External Defibrillators, U.S., 2004 – 2014
Chart 1-5: Total Market for Cardiac Ablation Catheters, U.S., 2004 – 2014
Chart 1-6: Unit Sales of Diagnostic Electrophysiology Catheters, U.S., 2004 – 2014
Chart 1-7: Total Market for Cardiac Monitoring Products, U.S., 2004 – 2014
Chart 1-8: Leading Competitors in the Cardiac Rhythm Management, Electrophysiology, and Ablation Market, U.S., 2007